Publications
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression
Marcelo Sobral-Leite, Simon P. Castillo, Shiva Vonk, Hendrik A. Messal, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman B. Hagos, Myrna van den Bos, Joyce Sanders, Mathilde Almekinders, Lindy L. Visser, Emma J. Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Jacco van Rheenen, E. Shelley Hwang, Yinyin Yuan, Grand Challenge PRECISION Consortium, Renee Menezes, Esther H. Lips & Jelle Wesseling. npj Precis. Onc. 9, 25 (2025).
doi: https://doi.org/10.1038/s41698-024-00769-6
News: A breakthrough in digital breast pathology: the journey to AIDmap | Cancer Grand Challenges
Conquering Overtreatment of DCIS: Lessons from PRECISION
Proteeti Bhattacharjee, Esther H. Lips, Elinor J. Sawyer, E. Shelley Hwang, Alastair M. Thompson, Jelle Wesseling on behalf of the Cancer Grand Challenges PRECISION Consortium. Cancer Discov (2025) 15 (1): 28–33.
doi: https://doi.org/10.1158/2159-8290.CD-24-1201
News: Lessons from global team science | Cancer Grand Challenges
Mechanisms that clear mutations drive field cancerization in mammary tissue
Marta Ciwinska, Hendrik A. Messal, Hristina R. Hristova, Catrin Lutz, Laura Bornes, Theofilos Chalkiadakis, Rolf Harkes, Nathalia S. M. Langedijk, Stefan J. Hutten, Renée X. Menezes, Jos Jonkers, Stefan Prekovic, Grand Challenge PRECISION consortium, Benjamin D. Simons, Colinda L. G. J. Scheele & Jacco van Rheenen. Nature 633, 198–206 (2024).
doi: https://doi.org/10.1038/s41586-024-07882-3
News: Team PRECISION: playing the long game to get an early view of tumourigenesis | Cancer Grand Challenges
An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ
Danalyn Byng, Michael Schaapveld, Esther H Lips , Frederieke H van Duijnhoven , Jelle Wesseling, Wim H van Harte, Valesca P Retèl. Future Oncol. 2024 Dec;20(40):3451-3462.
doi: https://doi.org/10.1080/14796694.2024.2421152
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS.
Engelhardt EG, Schmitz RSJM, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager JHE, Griffioen R, Bijker N, Mann RM, Retèl V, van Duijnhoven FH, Wesseling J, Bleiker EMA; Grand Challenge PRECISION Consortium. Breast. 2024 Jul 2;77:103764. Online ahead of print. PMID: 38970983
doi: https://doi.org/10.1016/j.breast.2024.103764
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.
Delaloge S, Khan SA, Wesseling J, Whelan T. Lancet. 2024 Jun 22;403(10445):2734-2746. Epub 2024 May 9. PMID: 38735296
doi: https://doi.org/10.1016/S0140-6736(24)00425-2
Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S, Voets MM, van Duijnhoven FH, Lips EH, Groen EJ, van Oirsouw MCJ, Hwang SE, Lo JY, Wesseling J, Mann RM, Teuwen J; Grand Challenge PRECISION Consortium Steering Group. Cancer Imaging. 2024 Apr 5;24(1):48. PMID: 38576031
doi: https://doi.org/10.1186/s40644-024-00691-x
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
Schmidt MK, Lips EH, Schmitz RS, Verschuur E, Wesseling J. BMJ. 2024 Jan 24;384:q22. PMID: 38267067
doi: https://doi.org/10.1136/bmj.q22
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Alaeikhanehshir S, Schmitz RSJM, van den Belt-Dusebout AW, van Duijnhoven FH, Verschuur E, van Seijen M, Schaapveld M, Lips EH, Wesseling J; and Grand Challenge PRECISION Consortium. Breast Cancer Res Treat. 2024 Feb;204(1):61-68. Epub 2023 Nov 14. PMID: 37964135
doi: https://doi.org/10.1007/s10549-023-07168-8
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts
Hutten S.J., Messal, H.A., Lips, E.H., Sheinman, M., Ciwinska,M., Braams, E., van der Borden, C., Kristel, P.,Stoffers, S., Wessels, L.F.A., Grand Challenge PRECISION Consortium, Jonkers,J., van Rheenen,J., Wesseling,J., Scheele, C.L.G.J. J Pathol 2024 Published online 23 May 2024.
doi: https://doi.org/10.1002/path.6289
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
R.S.J.M. Schmitz, A.W. van den Belt-Dusebout, K. Clements, Y. Ren, C. Cresta, J. Timbres, Y. Liu, D. Byng, T. Lynch, B.A. Menegaz, D. Collyar, T. Hyslop , S. Thomas, J.K. Love, M. Schaapveld, P. Bhattacharjee, M.D. Ryser, E. Sawyer, E.S. Hwang, A. Thompson, J. Wesseling, E.H. Lips, M.K. Schmidt, professor, Grand Challenge PRECISION. British Medical Journal, 2023 Oct 30:383:e076022
doi: https://doi.org/10.1136/bmj-2023-076022
News: https://cancergrandchallenges.org/news/changing-narrative-around-ductal-carcinoma-situ-and-breast-cancer-risk
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Wang K, Kumar T, Wang J, Minussi DC, Sei E, Li J, Tran TM, Thennavan A, Hu M, Casasent AK, Xiao Z, Bai S, Yang L, King LM, Shah V, Kristel P, van der Borden CL, Marks JR, Zhao Y, Zurita AJ, Aparicio A, Chapin B, Ye J, Zhang J, Gibbons DL; Grand Challenge PRECISION Consortium; Sawyer E, Thompson AM, Futreal A, Hwang ES, Wesseling J, Lips EH, Navin NE. Cell. 2023 Aug 31; 186(18):3968-3982.e15.
doi: https://doi.org/10.1016/j.cell.2023.07.024
Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial.
Renée S J M Schmitz, Ellen G Engelhardt, Miranda A Gerritsma, Carine M T Sondermeijer, Ellen Verschuur, Julia Houtzager, Rosalie Griffioen, Valesca Retèl, Nina Bijker , Ritse M Mann, Frederieke van Duijnhoven , Jelle Wesseling , Eveline M A Bleiker ; Grand Challenge PRECISION Consortium. Eur. J. Canc. 2023. Oct: 192:113276.
doi: https://doi.org/10.1016/j.ejca.2023.113276
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.
Danalyn Byng, Samantha M. Thomas, Christel N. Rushing, Thomas Lynch, Anne McCarthy, Amanda B. Francescatti, Elizabeth S. Frank, Ann H. Partridge, Alastair M. Thompson, Valesca P. Retèl, Wim H. van Harten, Lars J. Grimm, Terry Hyslop, E. Shelley Hwang, Marc D. Ryser. Radiology 2023.
doi: https://doi.org/10.1148/radiol.221210
Human Ductal Carcinoma In Situ: Advances and Future Perspectives.
Fariba Behbod, Jennifer H Chen and Alastair Thompson. Cold Spring Harb Perspect Med 2023 Oct 3;13(10):a041319.Online ahead of print.
doi: https://doi.org/10.1101/cshperspect.a041319
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
Jasmine Timbres , Kelly Kohut, Michele Caneppele, Maria Troy, Marjanka K. Schmidt , Rebecca Roylance and Elinor Sawyer. Cancers 2023, 15, 4397.
doi: https://doi.org/10.3390/cancers15174397
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.
Hutten, S.J., de Bruijn, R., Lutz, C., Badoux, M., Eijkman, T., Chao, X., Ciwinska, M., Sheinman, M., Messal, H., and Herencia-Ropero, A., Kristel, P., Mulder, L., van der Waal, R., Sanders, J., Almekinders, M.M., Llop-Guevara, A., Davies, H.R., van Haren, M.J., Martin, N.I., Behbod, F., Nik-Zainal, S., Serra, S., van Rheenen, J., Lips, E.H., Wessels, L.F.A., Grand Challenge PRECISION Consortium; Wesseling, J., Scheele, C.L.G. J., Jonkers, J. Cancer Cell 2023 41, 986-1002. e1009
doi: https://doi.org/10.1016/j.ccell.2023.04.002
News: https://cancergrandchallenges.org/news/unique-resource-studying-dcis-and-progression-cancer
Microcalcification crystallography as a potential marker of DCIS recurrence.
Gosling, S. B., Arnold, E. L., Davies, S. K., Cross, H., Bouybayoune, I., Calabrese, D., Nallala, J., Pinder, S. E., Fu, L., Lips, E. H., King, L., Marks, J., Hall, A., Grimm, L. J., Lynch, T., Pinto, D., Stobart, H., Hwang, E. S., Wesseling, J., Geraki, K., Stone, N., Lyburn, I.D., Greenwood, C., Rogers, K.D., Grand Challenge PRECISION Consortium. Scientific Reports 2023, 13(1).
doi: https://doi.org/10.1038/s41598-023-33547-8
News: https://cancergrandchallenges.org/news/microcalcification-crystallography-in-dcis
Classification performance bias between training and test sets in a limited mammography dataset.
Hou R, Lo JY, Marks JR, Hwang ES, Grimm LJ. PLoS One. 2024 Feb 7;19(2):e0282402. eCollection 2024.
doi: https://doi.org/10.1371/journal.pone.0282402
Mouse intraductal modeling of primary ductal carcinoma in situ.
Hutten SJ, Behbod F, Scheele CLGJ, Jonkers J. STAR Protoc. 2023 Aug 29;4(3):102526. Epub ahead of print. PMID: 37651235; PMCID: PMC10480770.
doi: https://doi.org/10.1016/j.xpro.2023.102526
MIND the translational gap: Preclinical models of ductal carcinoma in situ.
Hutten SJ, Jonkers J. Clin Transl Med.2023 Aug;13(8):e1376. PMID: 37620984; PMCID: PMC10449811.
doi: https://doi.org/10.1002/ctm2.1376
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.
Schmitz RSJM, Wilthagen EA, van Duijnhoven F, van Oirsouw M, Verschuur E, Lynch T, Punglia RS, Hwang ES, Wesseling J, Schmidt MK, Bleiker EMA, Engelhardt EG, Grand Challenge Precision Consortium.
Cancers (Basel). 2022 Jul 2;14(13):3259.
doi: https://www.mdpi.com/
Plain Language Summary (English): Click here
Plain Language Summary (Dutch): Click here
Learning to distinguish progressive and non-progressive ductal carcinoma in situ.
Casasent AK, Almekinders MM, Mulder C, Bhattacharjee P, Collyar D, Thompson AM, Jonkers J, Lips EH, van Rheenen J, Hwang ES, Nik-Zainal S, Navin NE, Wesseling J; Grand Challenge PRECISION Consortium.
Nat Rev Cancer. 2022 Dec;22(12):663-678.
doi: https://doi.org/10.1038/s41568-022-00512-y
A multi-modal exploration of heterogeneous physico–chemical properties of DCIS breast microcalcifications
Sarah Gosling, Doriana Calabrese, Jayakrupakar Nallala, Charlene Greenwood, Sarah Pinder, Lorraine King, Jeffrey Marks, Donna Pinto, Thomas Lynch, Iain D. Lyburn, E. Shelley Hwang, Grand Challenge PRECISION Consortium, Keith Rogers and Nicholas Stone
Analyst, 2022
doi: https://doi.org/10.1039/D1AN01548F
News: https://cancergrandchallenges.org/news/do-clues-breast-cancer-progression-lie-specks-seen-mammograms
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
Almekinders MM, Bismeijer T, Kumar T, Yang F, Thijssen B, van der Linden R, van Rooijen C, Vonk S, Sun B, Parra Cuentas ER, Wistuba II, Krishnamurthy S, Visser LL, Seignette IM, Hofland I, Sanders J, Broeks A, Love JK, Menegaz B, Wessels L, Thompson AM, de Visser KE, Hooijberg E, Lips E, Futreal A, Wesseling J; Grand Challenge PRECISION Consortium.
Br J Cancer. 2022 Oct;127(7):1201-1213.
doi: https://www.nature.com/articles/s41416-022-01888-2
Anomaly Detection of Calcifications in Mammography Based on 11,000 Negative Cases.
Hou R, Peng Y, Grimm LJ, Ren Y, Mazurowski M, Marks JR, King LM, Maley C, Hwang ES, Lo JY
IEEE Trans Biomed Eng. 69(5): 1639-1650.
doi: 10.1109/TBME.2021.3126281 (2022)
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Esther H. Lips, Tapsi Kumar , Anargyros Megalios , Lindy L. Visser , Michael Sheinman, Angelo Fortunato, Vandna Shah, Marlous Hoogstraat, Emi Sei, Diego Mallo , Maria Roman-Escorza , Ahmed A. Ahmed , Mingchu Xu, Alexandra W. van den Belt-Dusebout , Wim Brugman, Anna K. Casasent, Karen Clements, Helen R. Davies, Liping Fu, Anita Grigoriadis , Timothy M. Hardman, Lorraine M. King, Marielle Krete, Petra Kristel, Michiel de Maaker, Carlo C. Maley , Jeffrey R. Marks, Brian A. Menegaz, Lennart Mulder, Frank Nieboer, Salpie Nowinski, Sarah Pinder, Jelmar Quist, Carolina Salinas-Souza, Michael Schaapveld, Marjanka K. Schmidt, Abeer M. Shaaban , Rana Shami, Mathini Sridharan, John Zhang, Hilary Stobart, Deborah Collyar, Serena Nik-Zainal , Lodewyk F. A. Wessels, E. Shelley Hwang, Nicholas E. Navin, P. Andrew Futreal, Grand Challenge PRECISION consortium*, Alastair M. Thompson, Jelle Wesseling and Elinor J. Sawyer
Nat. Gen. 9th June 2022
doi: https://www.nature.com/articles/s41588-022-01082-3
Plain Language Summary (English): Click here
Plain Language Summary (Dutch): Click here
Plain Language Summary (Spanish): Click here
News: https://cancergrandchallenges.org/news/step-closer-avoiding-overtreatment-people-dcis
Video: https://cancergrandchallenges.org/news/collectively-our-work-could-ultimately-save-tens-thousands-people-burden-invasive-treatment
Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features
Rui Hou, Lars J. Grimm, MD, Maciej A. Mazurowski, Jeffrey R. Marks, Lorraine M. King, Carlo C. Maley, Thomas Lynch, Marja van Oirsouw, Keith Rogers, Nicholas Stone, Matthew Wallis, Jonas Teuwen, Jelle Wesseling, E. Shelley Hwang, Joseph Y. Lo
Radiology 2022; 000:1–9
https://doi.org/10.1148/radiol.210407
Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy
Yan Hong, Darlene Limback, Hanan S Elsarraj, Haleigh Harper, Haley Haines, Hayley Hansford, Michael Ricci, Carolyn Kaufman, Emily Wedlock, Mingchu Xu, Jianhua Zhang, Lisa May, Therese Cusick, Marc Inciardi, Mark Redick, Jason Gatewood, Onalisa Winblad, Allison Aripoli, Ashley Huppe, Christa Balanoff, Jamie L Wagner, Amanda L Amin, Kelsey E Larson, Lawrence Ricci, Ossama Tawfik, Hana Razek, Ruby O Meierotto, Rashna Madan, Andrew K Godwin, Jeffrey Thompson, Susan G Hilsenbeck, Andy Futreal, Alastair Thompson, E Shelley Hwang, Fang Fan, Fariba Behbod, Grand Challenge PRECISION Consortium
J Pathol 2022 Feb; 256(2):186-201.
doi: https://doi.org/10.1002/path.5820
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
Maartje van Seijen, Esther H. Lips , Liping Fu, Daniele Giardiello, Frederieke van Duijnhoven, Linda de Munck , Lotte E. Elshof, Alastair Thompson, Elinor Sawyer , Marc D. Ryser, E. Shelley Hwang, Marjanka K. Schmidt, Paula H. M. Elkhuizen, Grand Challenge PRECISION Consortium, Jelle Wesseling and Michael Schaapveld
Br J Cancer (2021); Aug 18
doi: https://doi.org/10.1038/s41416-021-01496-6
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.
Byng D, Retèl VP, Engelhardt EG, Groothuis-Oudshoorn CGM, van Til JA, Schmitz RSJM, van Duijnhoven F, Wesseling J, Bleiker E, van Harten WH, On Behalf Of The Grand Challenge Precision Consortium. Cancers. 2021 Aug 6;13(16):3962. PMID: 34439126; PMCID: PMC8394332.
doi: https://doi.org/10.3390/cancers13163962
Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
Byng D, Retèl VP, Schaapveld M, Wesseling J, van Harten WH; Grand Challenge PRECISION consortium.
Breast Cancer Res Treat. 2021 May;187(1):187-196.
doi: https://doi.org/10.1007/
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M. M. Almekinders, Michael Schaapveld, Bram Thijssen, Lindy L. Visser , Tycho Bismeijer, Joyce Sanders, Edoardo Isnaldi , Ingrid Hofland, Marjolijn Mertz, Lodewyk F. A. Wessels, Annegien Broeks, Erik Hooijberg , Wilbert Zwart, Esther H. Lips , Grand Challenge PRECISION Consortium*, Christine Desmedt and Jelle Wesseling
npj Breast Cancer (2021) 7:31, March 22
doi: https://doi.org/10.1038/s41523-021-00232-w
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
News: Could the size of fat cells around DCIS breast lesions predict risk of future invasive cancer? | Cancer Grand Challenges
News: How fat cells could help predict breast cancer | Netherlands Cancer Institute (nki.nl)
Blog: Predicting future breast cancer with precision – Cancer Research UK – Science blog
Variability in grading of ductal carcinoma in situ among an international group of pathologists
Maartje van Seijen, Katarzyna Józ´ wiak, Sarah E Pinder, Allison Hall, Savitri Krishnamurthy, Jeremy SJ Thomas, Laura C Collins, Jonathan Bijron, Joost Bart, Danielle Cohen, Wen Ng, Ihssane Bouybayoune, Hilary Stobart, Jan Hudecek, Michael Schaapveld, Alastair Thompson, Esther H Lips, and Jelle Wesseling * on behalf of the Grand Challenge PRECISION consortium.
J Pathol Clin Res 2021 Feb 23
doi: 10.1002/cjp2.201 (doi.org)
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
Daniele Giardiello, Iris Kramer, Maartje J. Hooning, Michael Hauptmann, Esther H. Lips, Elinor Sawyer, Alastair M. Thompson, Linda de Munck, Sabine Siesling, Jelle Wesseling, Ewout W. Steyerberg and Marjanka K. Schmidt
npj Breast Cancer 6, 60 (2020).
doi: https://doi.org/10.1038/s41523-020-00202-8
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Oncologieuptodate: Click Here
Prognostic value of histopathological DCIS features in a large scale international interrater reliability study
EmmaJ.Groen, Jan Hudecek, Lennart Mulder, Maartje van Seijen, Mathilde M.Almekinders, Stoyan Alexov, Anikó Kovács, Ales Ryska, Zsuzsanna Varga, Francisco Javier Andreu Navarro, Simonetta Bianchi, Willem Vreuls, Eva Balslev, Max V.Boot, Janina Kulka, Ewa Chmielik, Ellis Barbé, Mathilda J.de Rooij, Winand Vos, Andrea Farkas, Natalja E.Leeuwis Fedorovich, Peter Regitnig, Pieter J.Westenend, Loes F.S.Kooreman, Cecily Quinn, Giuseppe Floris, Gábor Cserni, Paul J.van Diest, EstherH.Lips, Michael Schaapveld, Jelle Wesseling on behalf of Grand Challenge PRECISION consortium
Breast Cancer Research and Treatment
doi: https://doi.org/10.1007/s10549-020-05816-x
Published online 30th July 2020
PRECISION Newsletter Volume 2, Issue 1, July 2020
https://www.dcisprecision.org/wp-content/uploads/2020/08/DCIS-Nieuwsbrief-Final_140820.pdf
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
Sena Alaeikhanehshir, Ellen G. Engelhardt, Frederieke H. van Duijnhoven, Maartje van Seijen, Patrick A. Bhairosing, Donna Pinto, Deborah Collyar, Elinor Sawyer, Shelley E. Hwang, Alastair M. Thompson, Jelle Wesseling, Esther H. Lips, Marjanka K. Schmidt on behalf of PRECISION
Breast 2020 Apr; 50: 95–103.
doi: 10.1016/j.breast.2020.02.006
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Calcification Microstructure Reflects Breast Tissue Microenvironment
Sarah Gosling, Robert Scott, Charlene Greenwood, Pascaline Bouzy, Jayakrupakar Nallala, Iain D. Lyburn, Nicholas Stone, Keith Rogers
Journal of Mammary Gland Biology and Neoplasia volume 24, pages333–342(2019)
doi: https://doi.org/10.1007/s10911-019-09441-3
Plain Language Summary (English): Click here
Plain Language Summary (Spanish): Click here
Plain Language Summary (Dutch): Click here
Ductal carcinoma in situ: to treat or not to treat, that is the question
Maartje van Seijen, Esther H. Lips, Alastair M. Thompson, Serena Nik-Zainal, Andrew Futreal, E. Shelley Hwang, Ellen Verschuur, Joanna Lane, Jos Jonkers, Daniel W. Rea and Jelle Wesseling on behalf of the PRECISION team
British Journal of Cancer volume 121, pages285–292(2019)
doi: https://doi.org/10.1038/s41416-019-0478-6
PRECISION Newsletter Volume 1, Issue 1, June 2019
https://www.dcisprecision.org/wp-content/uploads/2019/08/Final-Newsletter_11th-June-2019.pdf
Prediction of Upstaged Ductal Carcinoma in situ Using Forced Labeling and Domain Adaptation
Rui Hou, Maciej A. Mazurowski, Lars J. Grimm, Jeffrey R. Marks, Lorraine M. King, Carlo C. Maley, E. Shelley Hwang, and Joseph Y. Lo
IEEE Transactions on Biomedical Engineering (Early Access)
doi: 10.1109/TBME.2019.2940195
Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses
Lindy L. Visser, Emma J. Groen, Flora E. van Leeuwen, Esther H. Lips, Marjanka K. Schmidt, and Jelle Wesseling
Cancer Epidemiology, Biomarkers and Prevention
doi: 1055-9965.EPI-18-0976